[PERSON]
Tirzepatide
Featured in 7 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
259 clusters · 928 sources · last updated
Latest: Medical experts warn of weight regain risks for GLP-1 users
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr
Expanded therapeutic research and management of GLP-1 drugs
16 clusters · 102 sources · last updated
Latest: Semaglutide may reduce asthma attacks and impact weight maintenance
Medical research continues to expand the known therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. Beyond their primary uses for diabetes and obesity, these medications are being linked to
Tirzepatide clinical research and studies
2 clusters · 3 sources · last updated
Latest: Paraguay launches REAL-TIRZEPY study on diabetes and obesity
Clinical research regarding the drug tirzepatide has progressed from large-scale data analysis to specific real-world population studies. A study published in ‘The BMJ’ involving over 52,000 patients indicated that tir
Also covered in
-
Medical studies highlight new treatments for fatty liver and blood pressure
[HEALTH] · 2 sources ·